Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20
BW Businessworld

Dr Reddy's Laboratories launches Icosapent Ethyl Capsules in US

Shares of Dr Reddy's were trading 0.14 per cent lower at Rs 5,272.05 apiece on the BSE.

Photo Credit :

1465632012_6qcJyj_Pharma_Dr-reddy-870.jpg

Dr Reddy's Laboratories on Tuesday announced the launch of Icosapent Ethyl Capsules, used to reduce triglyceride (TG) levels in adult patients, in the US market.

The company has launched Icosapent Ethyl Capsules in 1 gram strength after approval by the US Food and Drug Administration (USFDA), Dr Reddy's said in a regulatory filing.

Dr Reddy's Icosapent Ethyl is available in 1 gram capsules in bottle count size of 120's count.

Dr Reddy's Icosapent Ethyl Capsules, 1 gram, is approved as an adjunct to diet to reduce triglyceride (TG) levels in adult patients with severe hypertriglyceridemia.

Shares of Dr Reddy's were trading 0.14 per cent lower at Rs 5,272.05 apiece on the BSE. 

(PTI)


Tags assigned to this article:
dr reddy usfda Ethyl Capsules shares